Compile Data Set for Download or QSAR
Report error Found 120 Enz. Inhib. hit(s) with all data for entry = 12702
TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721021(US12226414, Example 1)
Affinity DataIC50: 1.90nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721044(US12226414, Reference Compound 1)
Affinity DataIC50: 2.90nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721022(8-(6-(3-(dimethylamino)propoxy)pyridin-3-yl)-7-flu...)
Affinity DataIC50: 4.30nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721023(7-fluoro-1-isopropyl-3-methyl-8-(6-(3-(pyrrolidin-...)
Affinity DataIC50: 4.80nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721038(US12226414, Example 18)
Affinity DataIC50: 4.80nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721040(7-fluoro-3-methyl-8-(6-(3-(pyrrolidin-1-yl)propoxy...)
Affinity DataIC50: 6nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721037(8-(6-(3-(dimethylamino)propoxy)-2-fluoropyridin-3-...)
Affinity DataIC50: 7nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 10nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721039(8-(6-(3-(dimethylamino)propoxy)pyridin-3-yl)-7-flu...)
Affinity DataIC50: 13nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 25nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721027(7-fluoro-1-isopropyl-3-methyl-8-(6-((2-(piperidin-...)
Affinity DataIC50: 26nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 35nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 37nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721028(7-fluoro-1-isopropyl-3-methyl-8-(6-((2-(pyrrolidin...)
Affinity DataIC50: 51nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721025(8-(6-(3-((dimethylamino)methyl)pyrrolidin-1-yl)pyr...)
Affinity DataIC50: 65nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721041(8-(6-(3-((dimethylamino)methyl)pyrrolidin-1-yl)pyr...)
Affinity DataIC50: 97nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721026(US12226414, Example 6)
Affinity DataIC50: 100nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 363nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721034((S)-7-fluoro-8-(6-(3-(3-fluoropyrrolidin-1-yl)prop...)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721036(8-(6-(3-(3-azabicyclo[3.1.0]hexan-3-yl)propoxy)pyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721042(US12226414, Example 24)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721043((R)-7-fluoro-8-(6-(3-(3-fluoropyrrolidin-1-yl)prop...)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721033(US12226414, Example 13)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721035((R)-7-fluoro-8-(6-(3-(3-fluoropyrrolidin-1-yl)prop...)
Affinity DataIC50: 1.00E+3nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:ATR enzyme was made by ChemPartner (batch: CP-ATR-20161102-M2). 2× enzyme solutions were prepared in 1× kinase base buffer. 10 μl of 2× enzyme soluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:ATR enzyme was made by ChemPartner (batch: CP-ATR-20161102-M2). 2× enzyme solutions were prepared in 1× kinase base buffer. 10 μl of 2× enzyme soluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721031(8-(6-((2-(3-azabicyclo[3.1.0]hexan-3-yl)ethoxy)met...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721033(US12226414, Example 13)
Affinity DataIC50: 1.00E+4nMAssay Description:ATR enzyme was made by ChemPartner (batch: CP-ATR-20161102-M2). 2× enzyme solutions were prepared in 1× kinase base buffer. 10 μl of 2× enzyme soluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721033(US12226414, Example 13)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721032(US12226414, Example 12)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:ATR enzyme was made by ChemPartner (batch: CP-ATR-20161102-M2). 2× enzyme solutions were prepared in 1× kinase base buffer. 10 μl of 2× enzyme soluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721029((R)-7-fluoro-8-(6-((2-(3-fluoropyrrolidin-1-yl)eth...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721028(7-fluoro-1-isopropyl-3-methyl-8-(6-((2-(pyrrolidin...)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM682234(US20240207263, Ref Compd 1 | 7-fluoro-8-(6-((2-(4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: